Harmony Biosciences (HRMY) Short Interest Ratio & Short Volume → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free HRMY Stock Alerts $29.31 -0.39 (-1.31%) (As of 05/16/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Harmony Biosciences Short Interest DataCurrent Short Volume6,720,000 sharesPrevious Short Volume6,460,000 sharesChange Vs. Previous Month+4.02%Dollar Volume Sold Short$207.72 millionShort Interest Ratio / Days to Cover15.9Last Record DateApril 30, 2024Outstanding Shares56,792,000 sharesFloat Size41,870,000 sharesShort Percent of Float16.05%Today's Trading Volume340,312 sharesAverage Trading Volume393,133 sharesToday's Volume Vs. Average87% Short Selling Harmony Biosciences ? Sign up to receive the latest short interest report for Harmony Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHRMY Short Interest Over TimeHRMY Days to Cover Over TimeHRMY Percentage of Float Shorted Over Time Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. Harmony Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20246,720,000 shares $207.72 million +4.0%16.1%15.9 $30.91 4/15/20246,460,000 shares $190.70 million +1.7%21.0%17.6 $29.52 3/31/20246,350,000 shares $213.23 million +4.3%20.7%17.5 $33.58 3/15/20246,090,000 shares $194.76 million -3.2%19.8%16.9 $31.98 2/29/20246,290,000 shares $201.91 million -1.9%19.9%15.4 $32.10 2/15/20246,410,000 shares $224.73 million +0.9%20.3%15.1 $35.06 Get the Latest News and Ratings for HRMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Harmony Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/20246,350,000 shares $200.28 million +1.6%19.5%13.8 $31.54 1/15/20246,250,000 shares $195.75 million +3.5%19.2%10.7 $31.32 12/31/20236,040,000 shares $195.09 million +2.4%18.6%8 $32.30 12/15/20235,900,000 shares $198.65 million -0.8%18.1%7.8 $33.67 11/30/20235,950,000 shares $172.91 million +0.3%17.9%7.6 $29.06 11/15/20235,930,000 shares $149.44 million +11.1%17.9%7.4 $25.20 10/31/20235,340,000 shares $125.70 million -22.6%16.1%6.8 $23.54 10/15/20236,900,000 shares $145.66 million -1.6%20.3%9.4 $21.11 9/30/20237,010,000 shares $229.72 million -4.6%20.6%12.4 $32.77 9/15/20237,350,000 shares $275.77 million -5.0%21.6%13.8 $37.52 8/31/20237,740,000 shares $280.58 million +3.8%22.8%15.7 $36.25 8/15/20237,460,000 shares $245.36 million -2.1%22.0%16.6 $32.89 7/31/20237,620,000 shares $269.52 million -8.5%22.6%16.7 $35.37 7/15/20238,330,000 shares $294.47 million -1.2%24.7%16.7 $35.35 6/30/20238,430,000 shares $296.65 million +2.9%25.0%15.7 $35.19 6/15/20238,190,000 shares $297.05 million +2.1%24.3%9.6 $36.27 5/31/20238,020,000 shares $277.33 million +0.6%23.9%9.2 $34.58 5/15/20237,970,000 shares $291.22 million -2.3%23.8%8.5 $36.54 4/30/20238,160,000 shares $263.08 million +2.1%24.4%8.6 $32.24 4/15/20237,990,000 shares $251.76 million +7.0%24.1%8.9 $31.51 3/31/20237,470,000 shares $243.90 million +19.0%22.6%8 $32.65 3/15/20236,280,000 shares $255.22 million +8.3%19.0%10.6 $40.64 2/28/20235,800,000 shares $255.37 million +8.0%17.5%10.5 $44.03 2/15/20235,370,000 shares $262.16 million +5.5%16.3%10.2 $48.82 1/31/20235,090,000 shares $245.19 million -3.8%15.5%10.7 $48.17 1/15/20235,290,000 shares $250.85 million +21.1%16.2%10.5 $47.42 12/30/20224,370,000 shares $240.79 million +9.3%13.3%8.9 $55.10 12/15/20224,000,000 shares $224.52 million -26.1%12.5%8.8 $56.13 11/30/20225,410,000 shares $323.36 million -4.6%17.0%10.9 $59.77 11/15/20225,670,000 shares $318.09 million -1.7%17.8%11.5 $56.10 10/31/20225,770,000 shares $300.04 million +0.2%18.5%11.3 $52.00 10/15/20225,760,000 shares $294.16 million -5.0%18.5%10.8 $51.07 9/30/20226,060,000 shares $268.40 million +5.6%19.5%11.2 $44.29 9/15/20225,740,000 shares $257.96 million +9.5%18.5%10.1 $44.94[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. HRMY Short Interest - Frequently Asked Questions What is Harmony Biosciences' current short interest? Short interest is the volume of Harmony Biosciences shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 6,720,000 shares of HRMY short. 16.05% of Harmony Biosciences' shares are currently sold short. Learn More on Harmony Biosciences' current short interest. What is a good short interest ratio for Harmony Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HRMY shares currently have a short interest ratio of 16.0. Learn More on Harmony Biosciences's short interest ratio. What is a good short interest percentage for Harmony Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.05% of Harmony Biosciences' floating shares are currently sold short. Is Harmony Biosciences' short interest increasing or decreasing? Harmony Biosciences saw a increase in short interest in April. As of April 30th, there was short interest totaling 6,720,000 shares, an increase of 4.0% from the previous total of 6,460,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Harmony Biosciences' float size? Harmony Biosciences currently has issued a total of 56,792,000 shares. Some of Harmony Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Harmony Biosciences currently has a public float of 41,870,000 shares. How does Harmony Biosciences' short interest compare to its competitors? 16.05% of Harmony Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Harmony Biosciences: Schrödinger, Inc. (9.65%), Structure Therapeutics Inc. (10.35%), Protagonist Therapeutics, Inc. (6.36%), Edgewise Therapeutics, Inc. (10.36%), Kura Oncology, Inc. (13.59%), Supernus Pharmaceuticals, Inc. (9.16%), Taro Pharmaceutical Industries Ltd. (0.68%), Spyre Therapeutics, Inc. (12.81%), Ardelyx, Inc. (15.11%), Arcus Biosciences, Inc. (16.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Harmony Biosciences stock? Short selling HRMY is an investing strategy that aims to generate trading profit from Harmony Biosciences as its price is falling. HRMY shares are trading down $0.39 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Harmony Biosciences? A short squeeze for Harmony Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HRMY, which in turn drives the price of the stock up even further. How often is Harmony Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HRMY, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Schrödinger Short Interest Structure Therapeutics Short Interest Protagonist Therapeutics Short Interest Edgewise Therapeutics Short Interest Kura Oncology Short Interest Supernus Pharmaceuticals Short Interest Taro Pharmaceutical Industries Short Interest Spyre Therapeutics Short Interest Ardelyx Short Interest Arcus Biosciences Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HRMY) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe 1,000X Crypto PlaybookTrue Market InsidersGold Set to EXPLODE!Gold Safe ExchangeCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMost important medical advance in 100 yearsThe Oxford ClubBill Clinton Backing Biden Replacement???The Freeport SocietyCharles Payne Demystifies OptionsUnstoppable Prosperity